A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (B-MIND)
A Phase 2/3, Randomised, Multicentre Study of Tafasitamab With Bendamustine Versus Rituximab With Bendamustine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R-R DLBCL) Who Are Not Eligible for High-Dose Chemotherapy (HDC) and Autologous Stem-Cell Transplantation (ASCT)
Sponsor: Incyte Corporation
A PHASE2/PHASE3 clinical study on Diffuse Large B-cell Lymphoma, this trial is completed. The trial is conducted by Incyte Corporation and has accumulated 23 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
23 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE2/PHASE3
-
Aug 2025 — Sep 2025 [monthly]
Completed PHASE2/PHASE3
-
May 2025 — Aug 2025 [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — May 2025 [monthly]
Completed PHASE2/PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Status: Active Not Recruiting → Completed
▶ Show 18 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Sep 2022 — Jul 2024 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Jan 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE2_PHASE3
-
Sep 2021 — Jan 2022 [monthly]
Active Not Recruiting PHASE2_PHASE3
Status: Recruiting → Active Not Recruiting
-
May 2021 — Sep 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2020 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2019 — Apr 2020 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2019 — Jul 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Oct 2018 — Apr 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2018 — Oct 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Dec 2017 — Mar 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Sep 2017 — Dec 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2017 — Sep 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Feb 2017 — Jul 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Incyte Corporation
For direct contact, visit the study record on ClinicalTrials.gov .